Evidence map›Paper›PMID 39372887›Full record

ArticleBiologics : targets & therapy2024

Exploring Anticancer Potential of

Luolin Wang, Zhenglei Xu, Aarti Bains, Nemat Ali, Zifang Shang, Abhinandan Patil, Sandip Patil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biologics : targets & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. International journal of molecular sciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luolin Wang *Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People's Republic of China.
Zhenglei Xu *Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People's Republic of China.
Aarti BainsDeparment of Microbiology, Lovely Professional University, Phagwara, Punjab, India.
Nemat AliDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Zifang ShangResearch Experiment Center, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, Guangdong, People's Republic of China.
Abhinandan PatilDepartment of Pharmaceutics, D. Y. Patil Education Society (Deemed to be University), Kolhapur, Maharashtra, India.ORCID 0000-0002-1154-0753
Sandip PatilDepartment of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, People's Republic of China.ORCID 0000-0003-2736-9206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aims to systematically assess the anticancer potential of distinct Methods: Cytotoxicity was evaluated through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and exposure durations of Results: The study demonstrated a significant reduction in HCT 115 cell viability, particularly with Discussion:

Indexed as

apoptosiscancer therapeuticscytotoxicityhuman colorectal tumor 115Lactobacillus plantarumsheep milk

Identifiers

PMID39372887
PMCPMC11453158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.